-fold. Such a targeted virus could have therapeutic
into the viral membrane along with G protein (Schnell value in reducing HIV viral load. Our results also dem et al., 1996b) .
onstrate a general strategy of targeting one virus to the
In the studies reported here, we have generated VSV envelope protein of another virus to control infection.
recombinants with a complete deletion of the VSV G gene and have substituted instead the genes for CD4 Introduction and CXCR4. These viruses assemble particles containing both CD4 and CXCR4 in their envelopes and are To cause infection, membrane-enveloped viruses such targeted specifically to infect HIV-1-infected cells. as human immunodeficiency virus type 1 (HIV-1) must first bind receptors at the cell surface and subsequently Results fuse their own membrane with that of the cell. This fusion process releases the viral genetic material into the cyto-
Recovery of VSV Recombinants Expressing plasm and initiates infection. Entry of HIV-1 into cells
CD4 and CXCR4 has long been known to require virus binding to the cell Genetic engineering of nonsegmented negative strand surface molecule CD4 (Maddon et al., 1986; Sattentau RNA viruses such as VSV is complicated by the fact that and Weiss, 1988) , and recent studies have defined the minimal infectious unit of the virus is not RNA but chemokine receptor molecules CXCR4 (Berson et al., rather the viral RNA genome in a ribonucleoprotein com-1996; Feng et al., 1996) , CCR5 (Alkhatib et al., 1996;  plex composed of nucleocapsid (N) and polymerase Choe et al., 1996; Deng et al., 1996;  proteins (L and P). Infectious VSV can be recovered , and CCR3 ; Doranz from plasmid DNA as follows. Four separate plasmids et al., 1996) as coreceptors required for entry. HIV entry expressing the full-length antigenomic VSV RNA and the occurs in stages: initial binding of the viral envelope N, P, and L genes under control of bacteriophage T7 protein (designated gp120/41) to CD4 is followed by promoters are transfected into cells already infected conformational changes that allow binding to corecepwith a vaccinia virus recombinant expressing T7 RNA tor and subsequent coalescence of the viral and cellular . Intracellular assembly of the antimembranes (Lapham et al., 1996; Trkola et al., 1996; genomic RNA into nucleocapsids is followed by VSV et al., 1996) . HIV-infected cells express gp120/41 on the replication and transcription to generate infectious, repcell surface during infection and prior to its incorporation lication-competent VSV (Fuerst et al., 1986 ; Lawson et into budding HIV-1 particles. The presence of such molal., 1995; Whelan et al., 1995) . Additional genes can be ecules suggests the possibility that another virus might expressed from extra transcription units introduced into be engineered to carry HIV-1 receptor and coreceptor in the VSV genome (Schnell et al., 1996a) . its envelope and target specifically these HIV-1-infected
We reported previously the construction of a VSV recells.
combinant expressing the CD4 protein in addition to the Recent studies from our laboratory have focused on five VSV proteins N, P, M, G, and L (Schnell et al., 1996b) . developing vesicular stomatitis virus (VSV) as a high
To generate a VSV recombinant expressing CD4 and level expression vector capable of incorporating foreign CXCR4 instead of VSV G, the upstream VSV G gene proteins into the viral envelope (Schnell et al., 1996a, was deleted from the VSV-CD4 construct (Figure 1 ). The recovery of virus, designated VSV⌬G-CD4, was then accomplished by including a complementing plasmid ‡ To whom correspondence should be addressed. The order of the genes in wild-type VSV and in the recombinant VSVs described is shown. Each extra gene was inserted so that it contained the appropriate signals specifying VSV polymerase transcription initiation and termination. The details of plasmid constructions and derivation of the recombinant viruses are given in Experimental Procedures. The genes are transcribed from left to right from the negative strand RNA genome that is shown in the 3Ј-5Ј orientation.
encoding VSV G protein in addition to those encoding the virus particles were purified from the medium. Viral proteins were then separated by SDS-PAGE and de-N, P, and L. We next added the gene encoding CXCR4 at the position downstream of CD4 and recovered the tected by staining with Coomassie blue ( Figure 3A) . The wild-type virus contains the L, G, N, and M proteins (P virus, designated VSV⌬G-CC4. Because the recovered viruses are capable of only a single round of infection is a minor protein comigrating with N), while the VSV⌬G-CD4 and VSV⌬G-CC4 viruses lack G but contain a new on BHK cells, they were initially recovered and grown on cells infected with a vaccinia virus encoding the T7 protein of ‫000,55ف‬ Da, the size expected for CD4. In a previous study, we determined that the amount of CD4 RNA polymerase and transiently expressing a complementing VSV G protein from a transfected plasmid DNA. present in radiolabeled VSV-CD4 virions was about 25% of the level of VSV G (Schnell et al., 1996b) . We compared the amount of Coomassie-stained CD4 in those virions A Cell Line Expressing VSV G Protein Allows Growth of the Defective Viruses versus the VSV⌬G-CD4 and VSV⌬G-CC4 virions shown here and determined that CD4 was incorporated with In order to grow the VSV⌬G-CD4 and VSV⌬G-CC4 virus in the absence of vaccinia virus, we next generated a the same high efficiency relative to the other VSV proteins (data not shown). BHK cell line expressing the VSV G protein from an inducible promoter (Shockett et al., 1995) . Figure 2 The presence of CD4 in the particles was also verified by Western blotting ( Figure 3B , lanes 2 and 3) The shows that the VSV⌬G-CC4 virus forms plaques on this cell line, indicating multiple rounds of infection. Titers CXCR4 protein was not detected in VSV⌬G-CC4 by staining but was readily detected by Western blotting obtained after growing the defective viruses on this cell line were in the range of 0.5 ϫ 10 6 to 1 ϫ 10 6 pfu/ml. ( Figure 3B , lane 6). The lack of detection of CXCR4 in virions by Coomassie blue staining may be because it These titers are reduced at least 1000-fold compared to those of wild-type VSV, presumably because the levis present at lower levels than CD4, because it is broad band obscured by VSV N protein, or because proteins els of G protein provided by the complementing cell line are low compared to those expressed in wild-type that are extremely hydrophobic do not bind the stain. Budding of VSV in the absence of VSV G protein is infection.
known to be approximately 20-fold less efficient than budding in its presence (Knipe et al., 1977) . Similar reIncorporation of CD4 and CXCR4 into the Recombinant Viruses sults have been obtained for rabies virus (Mebatsion et al., 1996) . Although the amounts of protein detected by To determine if the CD4 and CXCR4 molecules were expressed from the defective viruses and incorporated staining in Figure 3A appear similar for all viruses, it should be noted that the virus loaded in lanes 2 and 3 into virus particles, we infected BHK cells (not expressing VSV G) with VSV⌬G-CD4 or VSV⌬G-CC4 that had was derived from 10 7 infected BHK cells, while the wildtype virus in lane 1 was from only 2 ϫ 10 5 , or 50-fold been grown on the BHK-G line (multiplicity of infection [moi] ϭ 5). After 16 hr, when all cells had been killed, fewer infected cells. Our results not only confirm the 
Ϫ3
, and 10 Ϫ4 ) were added 16 hr later followed by addition of 2 ml of DME containing 2% methylcellulose. Cells were incubated for 48 hr and then stained with napthalene black to visualize the small plaques. Wild-type VSV plaques are much larger and are visible after 18 hr, but plaque formation by the defective virus on this cell line was slower, probably because of the reduced level of complementing VSV G protein expressed.
Infection of HIV-1 Infected Cells by VSV⌬G-CC4
Because cells infected with HIV-1 have the gp120/41 envelope protein on their surface, we reasoned that it might be possible to infect these cells with VSV⌬G-CC4. The gp120/41 molecules present on the cell surface should bind to CD4 and CXCR4 on the virus surface and promote fusion of the viral and cell membranes. To test this possibility, we infected a human T cell line (Jurkat) with HIV-1 IIIB. At 5 days postinfection, when control experiments showed that about half of the cells were infected with HIV-1, we added VSV⌬G-CC4 virus. Two control cultures, one infected with HIV-1 only and another infected with VSV⌬G-CC4 only, were followed in parallel. We initially followed infection by HIV-1 and VSV⌬G-CC4 using indirect immunofluorescence microscopy to detect both HIV-1 proteins and VSV nucleocapsid (N) protein. An example of results from the immunofluorescence analysis at 19 days after HIV infection is shown in Figure 5 along with a Nomarski image of the tive for HIV-1 antigens ( Figures 5D and 5E ) and the majority of those cells were also positive for VSV N protein ( Figure 5F ), indicating that they had been superinfected importance of VSV G protein in driving highly efficient with VSV⌬G-CC4. We also noted rare cells that were virus budding but also illustrate that significant amounts strongly positive for VSV N protein expression but had of virus production occur even in the absence of VSV only little or no HIV protein evident. These cells may G protein.
result from shut off of cellular and HIV protein syntheTo examine the morphology of the recombinant virus sis by VSV⌬G-CC4 or from other mechanisms of inparticles and to verify that CD4 was exposed on the fection (see Discussion). In Jurkat cells infected with viral membrane, we examined purified virus particles by VSV⌬G-CC4 only, none of the cells showed the presence electron microscopy after labeling with antibody to CD4 of HIV or VSV N antigens (Figures 5H-5J). and a gold-conjugated secondary antibody. PhotoFrom the quantitation in Figure 6 , it is evident that graphs of negatively stained virus particles are shown when cells were infected with HIV-1 alone, the percentin Figure 4 . Wild-type VSV particles contained visible G age of HIV-1 ϩ cells rose to nearly 100% and remained protein spikes (arrows) and did not bind antibody to high throughout the experiment. When cells were first CD4, while the VSV⌬G-CD4 or VSV⌬G-CC4 viruses infected with HIV-1 and subsequently infected with lacked visible spikes and did bind anti-CD4 antibodies.
VSV⌬G-CC4, the percentage of HIV ϩ cells began to deThe antibody to the HA tag on CXCR4 that was used in crease at day 14 and plateaued at day 21 to levels Western blotting ( Figure 3B ) to show the presence of between 5% and 10% HIV ϩ . In addition, Figure 6 shows CXCR4 in the virions was not suitable for electron mithat the percentage of HIV-1 ϩ cells that were also incroscopy because the HA tag is expected to be inside fected with VSV⌬G-CC4 increased and then reached a plateau at around 90% to 95%. It therefore appears that the membrane. Purified wild-type VSV, VSV⌬G-CD4, or VSV⌬G-CC4 particles were negatively stained with phosphotungstic acid after labeling with a monoclonal antibody directed to CD4 followed by gold-conjugated goat anti-mouse IgG particles. Wild-type VSV particles contained visible spikes of VSV G protein trimers (arrows) and did not bind antibody to CD4 (wild-type VSV, left panel), while VSV⌬G-CD4 or VSV⌬G-CC4 bound anti-CD4 antibody and did not show visible spikes on the surface. cells infected with HIV-1 are rapidly superinfected with particles, we repeated the experiment shown in Figures 5 and 6 but instead followed HIV-1 titers and release of VSV⌬G-CC4 and killed before high levels of HIV-1 can be released. A balance is then reached between the two reverse transcriptase (RT) into the medium (Figures 7A and 7B) . At the time of addition of VSV⌬G-CC4 at 3 viruses where HIV infection is controlled by VSV⌬G-CC4 infection and maintained at low levels. Very similar days after HIV-1 infection, HIV titers and RT levels in the medium were low. In the control cells infected with HIV-1 results were obtained in an experiment performed with the H9 T cell line, another cell line in which HIV-1 IIIB alone or in the cells superinfected with VSV⌬G-CC4, both the HIV titers and RT activity peaked at 10 days grows well.
We also tested the possibility that the VSV⌬G-CD4 after infection. There was then a decline in RT activity by day 14 in cells superinfected with VSV⌬G-CC4 and virus lacking the coreceptor gene might infect HIV-1-infected cells. In one experiment, we observed a low a leveling off at about 10% of the RT level seen in control cells. The results with titers of infectious HIV-1 were level of infection by VSV⌬G-CD4 (about 10% of that observed with VSV⌬G-CC4). However, the initial infecmuch more dramatic, with a complete disappearance of infectious HIV-1 (Ͼ4 logs below the control) at day tion could be completely neutralized with antibody to VSV G, indicating that a trace of G protein sufficient to 14 followed by a fluctuation at levels of only 0 to 39 infectious particles per milliliter out to day 34. These start infection must have been present in the virions. This G protein was presumably carried into the BHK cell titers should be compared to persistent titers of ‫01ف‬ 4 / ml for the control culture that was not infected with line from the input virus grown in the BHK-G line and then incorporated into exiting virions. Interestingly, once VSV⌬G-CC4. The RT results were consistent with what we had seen the infection was established in HIV-infected Jurkat cells, it persisted for several weeks, indicating that the previously with the immunofluorescence in Figure 6 , but the much larger decreases in infectious HIV titers were virus could propagate without encoding its own coreceptor. Presumably budding virions can pick up cellnot expected. These lower titers could be explained if the VSV⌬G-CC4 infection selected for HIV-infected cells encoded coreceptor and are then able to propagate. However, control of HIV-1 infection was not as strong that expressed little or no HIV envelope and thus produced HIV particles lacking envelope but containing RT. as with VSV⌬G-CC4, indicating that it is preferable to have the virus encode high levels of the coreceptor. Because the control of HIV infection was less effective Anti-CD4 or Anti-gp120 Block Infection without coreceptor, we did not pursue further studies by VSV⌬G-CC4 with this virus.
We also performed control neutralization experiments ( Table 1 ) to verify that entry of VSV⌬G-CC4 into HIV-VSV⌬G-CC4 Infection Controls Release infected cells was dependent on CD4 and gp120. in Infectious HIV-1 VSV⌬G-CC4 was incubated with antibody to CD4, neuTo obtain measurements of the effects of VSV⌬G-CC4 on production of infectious HIV-1 and on release of HIV-1 tralizing antibody to VSV-G, or without antibody before Titers determined by this assay were consistent with titers determined by an indirect immunofluorescence assay detecting HIV antigens. RT activity (B) is reported in total counts per minute (cpm) addition to Jurkat cells that had been infected with HIV-1 bound to the DEAE paper after subtraction of a backgrounds of for 5 days as in Figure 6 . (Till et al., 1988) . These cells were readily infected by wild-type VSV, but we did not observe any infection by VSV⌬G-CC4. We have derived a novel virus, VSV⌬G-CC4, that lacks gate only in cells that are first infected with HIV-1 and about half of which were HIV-1-infected and half were that are worth noting. First, because VSV⌬G-CC4 is specifically targeted to cells already infected with HIV-1, uninfected, superinfection with VSV⌬G-CC4 ultimately limited production of infectious HIV-1 to levels that were the VSV⌬G-CC4 infection level would be expected to parallel HIV infection and thus decline with HIV clearbarely detectable or undetectable, at least 300-fold to 10 4 -fold lower than HIV titers produced by control cells ance. Second, VSV⌬G-CC4 encodes only human proteins as its envelope proteins and thus would not induce that were not superinfected with VSV⌬G-CC4. This reduction presumably is the result of killing of the HIV-1-production of neutralizing antibodies. The internal VSV proteins would be expected to induce cytotoxic T cell infected cells by the VSV⌬G-CC4 virus. The reduction in HIV-1 titers was greater than would have been predicted responses, but such responses might help in clearing HIV infection by rapidly killing cells infected with HIV-1 from analysis of the number of HIV-1-infected cells or from RT assays. The number of HIV ϩ cells was reduced and VSV⌬G-CC4. Third, mutations to drug resistance are rapidly selected in HIV-1, but resistance to infection about 10-fold by the VSV⌬G-CC4 infection, and the release of RT was reduced to a similar extent. In considerby VSV⌬G-CC4 would require loss of HIV's ability to bind CD4 or coreceptor and would therefore not be ing the mechanism of VSV⌬G-CC4 action, this discrepancy is reasonable since VSV⌬G-CC4 will target and kill selected. Given the complexity of HIV-1 infection in humans, those cells expressing HIV envelope protein and thus select for cells that produce little or no HIV envelope.
clinical trials will be required to determine the value of our approach. The CXCR4 coreceptor (Feng et al., 1996) Such cells would still score positive for HIV-1 antigen production and would produce normal levels of HIVis used by the T cell-tropic syncytium-inducing HIV-1 strains that typically predominate in late stage HIV dislike particles containing RT, but the majority of these particles would be noninfectious.
ease (see Moore, 1997, for review). The VSV⌬G-CC4 virus might therefore be directly applicable in limiting The persistence of a low level of both HIV-1 and VSV⌬G-CC4 coinfection for over 1 month in culture indi-HIV-1 production in late stage patients. Clinical stage is strongly associated with all measures of virus load cates that both viruses are continuing to replicate and that they have reached a balance. Based on our analysis (reviewed by Weiss, 1993) , and HIV virus load might be significantly reduced by VSV⌬G-CC4. Because the so far, it seems unlikely that VSV⌬G-CC4 will ever completely eliminate the HIV-1 infection in the culture. This VSV⌬G-CC4 virus can replicate continuously in HIVinfected cells, multiple treatments might not be required. low level persistence may occur because VSV⌬G-CC4 can only infect HIV-1-infected cells after gp120/41 is We are also introducing genes for other coreceptors such as CCR5 or CCR3 into the VSV⌬G-CD4 virus in an expressed on the cell surface and such cells likely release some HIV-1 before they are killed.
attempt to target macrophage-tropic HIV-1 strains that typically predominate early in HIV infection (Choe et al., The VSV⌬G-CC4 virus infects cells that have already been infected with HIV-1, but it may also be fusing di-1996; Schuitemaker and Miedema, 1996; Moore, 1997) . rectly with HIV-1 virions. Such fused viruses would contain the nucleocapsids of HIV and VSV and might be Our results also illustrate an important aspect of VSV budding and assembly. Based on virus protein yields able to initiate infection if sufficient gp120/41 were still present on the membrane. Such an infection would aland titers, we estimate that each BHK cell infected with wild-type VSV produces approximately 100,000 partimost certainly favor replication of VSV⌬G-CC4, because VSV would shut off cellular protein synthesis in 2 to cles, and up to 10% of these particles are infectious. The deletion of the VSV G gene reduced particle yields 3 hr, even before HIV had sufficient time for reverse transcription and integration. Infection by these fused of VSV⌬G-CC4 or VSV⌬G-CD4 approximately 30-to 50-fold, indicating a substantial role for G in promoting viruses could explain the presence of occasional cells ( Figure 5 ) that are making VSV proteins but do not appear budding. However, despite this reduced budding, at least 2,000 particles of VSV⌬G-CC4 or VSV⌬G-CD4 are to have synthesized HIV proteins. It is also possible that VSV has inhibited HIV protein synthesis in these cells.
produced from each BHK cell in the absence of G protein. The incorporation of CD4 and CXCR4 into these Infection of uninfected cells by VSV⌬G-CC4 might also occur if VSV⌬G-CC4 pseudotypes carrying HIV envelope particles is presumed to occur by a passive process of protein trapping as virus buds from the cell surface, protein were generated in HIV-infected cells. Incorporation of the wild-type HIV envelope into VSV particles is because neither protein would be expected to contain specific signals promoting incorporation. Because VSV extremely inefficient (Johnson et al., 1997) , and therefore this latter mechanism would likely be rare. To test diblocks host protein synthesis and expresses extremely large amounts of its mRNA and proteins, CD4 and rectly for such pseudotypes, we carried out a shortterm infection of Jurkat cells with supernatants from CXCR4 are likely to be the major proteins present on cell surface and therefore the major proteins in the cells coinfected with HIV-1 and VSV⌬G-CC4. VSV protein expression was not detected in these cells, while VSV⌬G-CC4 envelope.
Our results also suggest a general strategy of virus it was readily detected by using the same supernatant to infect HIV-infected Jurkat cells. We conclude that the targeting to infected cells in cases where receptor(s) recognized by viral envelope proteins are known and VSV⌬G-CC4(HIV) pseudotypes are extremely rare if they exist at all. the viral envelope protein has membrane fusion activity. Specific targeting of defective VSVs to kill other cells Although our results indicate that the VSV⌬G-CC4 virus can control HIV infection in a T cell line, more work (e.g., cancer cells) might also be possible if genes for specific antibodies and a membrane fusion protein were is needed to determine if it will have therapeutic value. There are however some positive aspects of this system incorporated into VSVs lacking the G gene.
Experimental Procedures
cell debris and nuclei were removed by centrifugation at 1,250 ϫ g for 5 min, and virus was then purified twice by ultracentrifugation at 120,000 ϫ g through a 20% sucrose solution containing 10 mM Plasmid Construction Digestion with MluI and SphI was used to delete the entire VSV G Tris-HCl (pH 7.5) and 1 mM EDTA. Virus pellets were resuspended and analyzed by SDS-PAGE (10% acrylamide). Gels were either gene from pVSV-CD4 (Schnell et al., 1996b) . The resulting plasmid was designated pVSV⌬G-CD4. A plasmid encoding the CXCR4 prostained with Coomassie brilliant blue or transferred to nitrocellulose membranes. Membranes were blocked with 5% low fat milk powder tein with an HA epitope tag was described previously (Berson et al., 1996) . CXCR4 was amplified by PCR from this plasmid with in TBST (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.05% Tween-20) for 1 hr at room temperature and then incubated with an antibody VENT polymerase (Stratagene) using primers 5Ј-ACTGCCCGGGCT CGAGGTTACCATGGAGGGGATCAG-3Ј and 5Ј-AGCTGCGGCCGCT directed against CD4 (sheep ␣-CD4, AIDS Research Reference and Reagent Program [ARRRP]) or an antibody 12CA5 (Boehringer AGCTTAGCTCCCGGGAAGAGATGCG-3Ј. The first primer contains an XhoI site and the second an NheI site (italic letters). The PCR Mannheim) directed against the HA epitope in CXCR4. Proteins were visualized after incubation with horseradish peroxidase-conjugated product was digested with XhoI and NheI and cloned into pVSV-XN1 (Schnell et al., 1996a ) that was digested with XhoI and NheI. The donkey anti-sheep IgG or horseradish peroxidase-conjugated goat anti-mouse IgG (Jackson Research) for 1 hr at room temperature resulting plasmid was designated pVSV-CXCR4. The G gene was deleted from pVSV-CXCR4 with XhoI and MluI. The coding sequence using enhanced chemiluminescence (ECL; Amersham) system. for human CD4 was amplified from pCD4 (Shaw et al., 1989) by PCR using primers 5Ј-CCGGGTACCACGCGTACAATGAACCGGGGAGT Electron Microscopy and Labeling with CCCTTTTAG-3Ј and 5Ј-GGGCCCCTCGAGCGTGATATCTGTTAGTT Gold-Conjugated Antibodies TTTTTCATACTC AAATGGGGCTACATGTCTTC-3Ј. The first primer
Virus particles from infection of approximately 10 7 cells on a 15 cm contains an MluI site (italic letters); the second primer contains an dish were recovered from the culture medium by first pelleting cell XhoI site (italic letters) and a VSV transcription stop-start signal debris at 1,500 ϫ g for 10 min. The virus was then concentrated (underlined letters). The CD4 gene was inserted at the site of the G and purified by centrifugation as described above. Virus samples deletion to generate a plasmid that was designated pVSV⌬G-CC4.
were absorbed onto carbon-coated grids for 5 min and then blocked with 1% BSA in PBS for 10 min at room temperature. The grids were then placed on a 50 l drop of anti-CD4 MAb OKT4 (Reinherz Construction of a BHK Cell Line Expressing VSV G Protein The tetracycline-regulated system employed was described preet al., 1979) diluted 1:50 in PBS containing 1% BSA. After 1 hr, excess antibody was removed by placing grids sequentially onto viously (Shockett et al., 1995) . A VSV G gene was prepared from a plasmid designated pBSG by digestion with XhoI. Extensions were five 50 l drops of 1% BSA in PBS for 2 min each time. The grids were then placed on a 50 l drop of goat anti-mouse IgG (Fc) labeled filled in with Klenow enzyme and the fragment ligated to pTet-Splice (Life Technologies) that had been cleaved with EcoRV. The resulting with 15 nm gold particles (AuroProbe, Amersham). Unbound gold conjugates were removed by five sequential 2 min washes with PBS. plasmid was called pTET-G. BHK cells on 10 cm plates (20% confluent) were transfected with 1 g pTET-G and 10 g pTet-TAk (Life The virus-immunogold complexes were then negative stained by incubation of the grids for 4 min on 50 l drops of 2% phosphotungTechnologies) using the CaPO 4 method (mammalian transfection kit; Stratagene). One day after transfection, 0.5 g/ml tetracycline stic acid (pH 7.2). Excess stain was removed and the grids were air dried. Images of viruses were obtained with a Zeiss EM910 electron was added to suppress G protein expression, which is toxic to BHK cells, and stable transfected cells were selected by adding 0.75 mg/ microscope. ml geneticin (G418). Ten days after transfection, cell colonies were isolated and, after induction by removal of tetracycline, they were Infection and Immunofluorescence Microscopy screened for expression of VSV G protein by immunofluorescence of Infected Jurkat Cells microscopy.
Approximately 3 ϫ 10 6 Jurkat cells (clone E6-1, ATTC #TIB-125) were seeded in T-25 flasks and grown in RPMI medium supplemented with 10% FBS. Infection with HIV-1 strain IIIB was at an Recovery of VSV Recombinants Baby hamster kidney cells (BHK-21, ATCC) were maintained in moi of approximately 0.01. At 5 days postinfection, cells were superinfected with VSV⌬G-CC4 virus derived from 5 ϫ 10 6 infected BHK DMEM (Dulbecco's modified Eagle's medium) supplemented with 5% fetal bovine serum (FBS). Cells on 10 cm dishes ‫%08ف(‬ conflucells in 5 ml medium. As controls, one HIV-infected culture was not superinfected, and a third culture was infected only with VSV⌬G-ent) were infected at an moi of 10 with vTF7-3 (Lawson et al., 1995) . After 1 hr, plasmids encoding the N, P, G, and L proteins and the CC4. Cells were collected for analysis at each time point as follows. One half of the volume of the culture was collected, and an equal appropriate recombinant antigenome RNA were transfected into the cells using a cationic liposome reagent containing dimethyldioctavolume of RPMI supplemented with 10% FBS was added back to the original cultures. Cells were pelleted at 1000 rpm for 5 min at decyl ammonium bromide and phosphatidylethanolamine (Rose et al., 1991; Lawson et al., 1995) . Plasmid amounts were 10 g of the 5ЊC in an IEC Centra-7R refrigerated centrifuge (Fisher Scientific). The media was discarded, cells were washed once in 5 ml PBS, and respective full-length plasmid (VSV⌬G-CD4 or VSV⌬G-CC4), 3 g pBS-N, 5 g pBS-P, 4 g BS-G, and 1 g pBS-L. Supernatants of pelleted again. The PBS was removed and cells were resuspended in 100 l PBS. The cells were then fixed in 1 ml of 3% paraformaldehyde recoveries were filtered through 0.22 m filters, and 5 ml was used to infect BHK-G cells on 10 cm plates that had been induced for for 1 hr at room temperature or overnight at 4ЊC. After permeabilization in 1% Triton X-100, cells were stained with a monoclonal anti-12 hr by removal of tetracycline. Supernatants of the first passage were filtered twice through a syringe filter (0.1 m pore size) to body to VSV N protein and with human polyclonal HIV immunoglobulin (ARRRP), followed by rhodamine-conjugated anti-mouse and remove any vaccinia virus, and the viruses were then passaged on 4 ϫ 10 6 BHK-G cells. Supernatants (10 ml) were titered on BHK-G FITC-conjugated anti-human antibodies (Jackson Research). Cells were examined and photographed with 40ϫ planapochrocells and frozen at Ϫ80ЊC. For production of virus stocks, 2 ϫ 10 6 BHK cells on 10 cm plates were infected for 2 hr with 10 ml supernamat objective on a Nikon Microphot-FX microscope equipped for epifluorescence. tants of VSV⌬G-CD4 or VSV⌬G-CC4 grown on BHK-G cells, washed three times with phosphate-buffered saline (PBS), followed by addiInfection of cells with HIV-1 or VSV⌬G-CC4 was monitored by counting at least three random fields of cells that typically contained tion of 10 ml RPMI medium with 10% fetal bovine serum (FBS) or 10 ml DMEM with 5% FBS. At 16 hr after infection, supernatants 100 to 200 cells. Syncytia were counted as single cells. were clarified by centrifugation and used for experiments or stored at Ϫ80ЊC.
Determination of HIV Titers HIV titers were obtained using supernatants from infected cultures and making serial 3-fold dilutions in 96-well plates. Ten thousand Preparation and Analysis of Viruses For isolation of virions, a monolayer of BHK cells ‫%08ف(‬ confluent)
MT-2 cells (ARRRP) were added to each well, and the virus and cells were mixed by pipeting. Plates were incubated at 37ЊC for 3 on a 10 cm dish was infected with VSV⌬G-CD4 or VSV⌬G-CC4 (moi ϭ 5), or VSV wild type (moi ϭ 0.01). At 16 hr after infection, to 5 days and scored for the presence of syncytia. Titers at each
